RN
Rennova Health, Inc.
RNVA · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $4.31M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
87 /100
Cheap EV/EBITDA 11.06x
P/S 0.23x
P/FCF 1.42x
Growth
100 /100
Growing Rev. growth 37.42%
EPS growth N/A
FCF growth N/A
Profitability
57 /100
Moderate Gross margin 59.46%
Net margin 41.36%
FCF margin 16.25%
Quality
16 /100
Poor ROIC 12.76%
ROA 38.16%
Asset turnover 0.92x
Debt
3 /100
High Current ratio 0.16x
Int. coverage 0.78x
Net debt/EBITDA 8.09x
Stability
43 /100
Moderate Beta -0.05x
Rev. volatility 185.81%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RNVA
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Seamus Lagan
Employees
96
Headquarters
West Palm Beach